Trillium Therapeutics Inc. (TRIL)

Today's Latest Price: $18.71 USD

1.42 (-7.05%)

Updated Dec 1 4:00pm

Add TRIL to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

Trillium Therapeutics Inc (TRIL) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Trillium Therapeutics Inc.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
6 $28 $14 $21.5 $20.13 6.81%

TRIL Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 8 0 0 0 0 8

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for TRIL as an investment opportunity.

  • The percent of analysts bearish on the stock of TRIL is less than nearly 100% of all US stocks.
  • Trillium Therapeutics Inc's number of analysts covering the stock is higher than 95.9% of stocks in the micro market cap category.
  • Trillium Therapeutics Inc's variance in analysts' estimates is lower than 11.45% of stocks in the micro market cap category.
  • Trillium Therapeutics Inc's upside potential (average analyst target price relative to current price) is greater than 13.16% of Pharmaceutical Products stocks.
  • Trillium Therapeutics Inc's percentage of analysts bullish on the stock is higher than 82.06% of all US stocks.
  • TRIL has a greater average analyst price target than 79.7% of stocks in the micro market cap category.
  • TRIL has a lower change in bullishness amongst analysts than nearly 100% of all US stocks.

Stocks similar to Trillium Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are KALV, ETTX and TGTX.

What is the outlook for TRIL? Use POWR Ratings for clearer insight into price direction.



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.5486 seconds.